Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

While most populations cannot afford the available HIV drugs, health professionals in North America continue incorporating new HIV drugs into health care to improve patient conditions. Europe is ...

For years, a preventive treatment that can significantly decrease the risk of contracting HIV has been available in Nova ...

New Drug Shows Promise in Clearing HIV from Brain July 25, 2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...

Negotiators at a U.N. conference in Colombia agreed to launch a fund for companies that make money from nature to give a ...

Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is ...

In recent years, HIV has spread rapidly among people who inject drugs, because users sometimes share needles when they don’t ...

Most recently, the HIV community has been very excited about a new PrEP drug called lenacapavir. This is an injectable form of PrEP that only needs to be given every six months. In trials among ...

The country’s successful rollout of HIV anti-retroviral drugs has lulled many into a false sense of security around ...

David Munar, who was appointed CEO in April, says the provider is on the "right track," but it will take time.